Collaborate with Parc Taulí

We research new oncological therapies, improving treatments, and new diagnostic tools based on new technologies.

We are benchmarks in research into the prevention of the risk of suicide in the young and adult population. Our groups develop studies in other areas of mental health such as depression or psychotic disorders for the improvement of functionality and prevention of these diseases.

We conduct research in diabetes from different approaches, in genetic obesity, and in pathologies of the digestive system that can predispose to cancer (such as inflammatory bowel and liver disease).

We are benchmarks in assistance and research for minority diseases prevalent in our population, such as Prader Willi syndrome, Angelman syndrome or cystic fibrosis. We also investigate improvements in treatment and diagnosis in growth disorders or childhood obesity.

Explanation of the research group

We research and innovate to improve the diagnosis and treatment of infectious pathologies, such as sepsis and antibiotic resistance, and we are benchmarks in the research of inflammatory and immune diseases, and critical patient illness.

We promote the application of new technologies (such as 3D printing and artificial intelligence) to advance knowledge and improve surgical patient care with innovative solutions.